Moderna Inc
Research Moderna Inc (MRNA) on Bullrun: market cap USD 27.66B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMRNA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 27.66B
- Financial periodFY2025
- RevenueUSD 1.94B
- Revenue growth-39.9%
- Net income-USD 2.82B
- Free cash flow-USD 2.07B
- Gross margin55.3%
Valuation Snapshot
latest market cap is USD 27.66B.
About Moderna Inc
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines;
Frequently asked questions
What is Moderna Inc's market cap?
Moderna Inc's market capitalization is USD 27.66B.
What does Moderna Inc do?
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine;